Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A12324 | Pages: NA | Charts: NA | Tables: NA |
Fungal testing kit is used as a fungal infection diagnostic kit in clinics, hospitals, and diagnostic centers. This kit is a serological assay that helps in qualitatively detecting beta-glucan in the serum of a patient who is showing symptoms of invasive fungal infections. Beta-glucans are polysaccharides found in the cell wall of fungi. By detecting a fungal infection, healthcare professionals can prescribe treatment for the specific fungi type. The sample collected by fungal testing kits is taken from body fluids, blood, scrapings of skin, nail, hair, or tissues . Tissue samples are taken for biopsy when there are symptoms of a deep infection.
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in December, 2019. This highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since its outbreak, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
At the early phase of the COVID-19 pandemic, there was no availability of any specific diagnostic test to detect the disease in patients. Alternative diagnostic tests were used initially but were not much effective. This unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their COVID-19 diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced COVID-19 diagnostics kits into local as well as global markets. These players achieved an edge over other diagnostics players, capitalizing on the opportunity from demand for COVID-19 diagnostic tests, which, in turn, helped them in maintaining their revenue in such a crisis.
However, with COVID-19, the supply chain of the raw material required to manufacture fungal testing kits and products for Down syndrome was disrupted in many countries. In addition, the market growth of diagnostic products is also declining as the manufacturers of diagnostic kits have slowed down their production because of the pandemic. This, in turn, is expected to have a significant impact on the fungal testing kits market.
Top Impacting Factors
Key Market Trends
Players such as GenMark Diagnostics, Inc. and La-Roche have released serological assays in the market such as the COBAT LIAT PCR system. This system consists of ePlex blood culture identification panel serological assay to help identify fungal infection subtypes.
In 2019, the acquisition of Brammer Bio was announced by Thermo Fisher Scientific. This acquisition helped Thermo Fisher Scientific enhance its laboratory services and product portfolio for fungal testing kits.
North America has emerged as the global leader in the fungal testing kits market. This can be attributed to the high prevalence of infectious diseases. In addition, the awareness regarding various fungal diseases has also escalated in this region which has increased the need for fungal testing kits.
In Asia-Pacific, the fungal testing kits market is expected to grow in countries like South Korea, China, India, and Japan. These nations represent growth potential in the wake of increasing healthcare expenditure and a huge patient pool. Infections such as invasive fungal diseases and candidiasis are also rampant in these aforementioned nations. This boosts the growth of the fungal testing kits market.
Key Benefits of the Report
Questions Answered in the Fungal Testing Kits Report
Key Market Segments
Key Market Players